Testing effectiveness (Phase 2)Looking for participantsNCT07585760
What this trial is testing
CM336 Plus Isatuximab for Newly Diagnosed Multiple Myeloma With Renal Impairment
Who this might be right for
Multiple Myeloma (MM)Multiple Myeloma Light Chain Induced Renal Insufficiency
Institute of Hematology & Blood Diseases Hospital, China 26